CIK 0001453687 · Non-accelerated filer<br>Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-08 | Kurtoglu Metin Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | +213,820 | 213,820 | ||
| 2024-04-08 | Kurtoglu Metin Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | −427.65 | 0 | ||
| 2024-04-08 | Kurtoglu Metin Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | +14,254 | 14,254 | ||
| 2024-04-08 | Kurtoglu Metin Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | −427.65 | 0 | ||
| 2024-04-08 | Kurtoglu Metin Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | +14,254 | 14,254 | ||
| 2024-04-08 | Hoge Elizabeth 10% owner | Conversion | +2,926,764 | 3,036,887 | ||
| 2024-04-08 | Hoge Elizabeth 10% owner | Conversion | +491,853 | 506,377 | ||
| 2024-04-08 | Hoge Elizabeth 10% owner | Conversion · Series A Non-Voting Convertible Preferred Stock | −87,802.95 | 101,953.44 | ||
| 2024-04-08 | Hoge Elizabeth 10% owner | Conversion · Series A Non-Voting Convertible Preferred Stock | −14,755.61 | 0 | ||
| 2024-03-26 | SPRINGER TIMOTHY A Director | Option exercise | +1,970,443 | $1.46 | $2.9M | 33,043,849 |
| 2024-03-26 | SPRINGER TIMOTHY A Director | Option exercise · Warrant (Right to Buy) | −1,970,443 | 0 | ||
| 2024-03-18 | SPRINGER TIMOTHY A Director | Purchase | +800 | $0.61 | $488 | 104,818 |
| 2024-03-18 | SPRINGER TIMOTHY A Director | Purchase | +19,044 | $0.60 | $11K | 31,073,406 |
| 2024-03-15 | SPRINGER TIMOTHY A Director | Purchase | +1,200 | $0.56 | $672 | 104,018 |
| 2024-03-15 | SPRINGER TIMOTHY A Director | Purchase | +537,500 | $0.59 | $315K | 31,054,362 |
| 2024-03-14 | SPRINGER TIMOTHY A Director | Purchase | +2,000 | $0.53 | $1K | 102,818 |
| 2024-03-14 | SPRINGER TIMOTHY A Director | Purchase | +648,372 | $0.54 | $352K | 30,516,862 |
| 2024-03-13 | SPRINGER TIMOTHY A Director | Purchase | +3,200 | $0.58 | $2K | 100,818 |
| 2024-03-12 | SPRINGER TIMOTHY A Director | Purchase | +1,200 | $0.61 | $735 | 97,618 |
| 2024-03-11 | SPRINGER TIMOTHY A Director | Purchase | +1,200 | $0.65 | $785 | 96,418 |
Page 12 of 16 · 316 trades